Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

40.42
-0.4600-1.13%
Pre-market: 40.420.00000.00%07:38 EDT
Volume:85.59K
Turnover:3.43M
Market Cap:301.13M
PE:- -
High:40.43
Open:40.36
Low:39.72
Close:40.88
52wk High:43.44
52wk Low:23.90
Shares:7.45M
Float Shares:7.45M
Volume Ratio:0.47
T/O Rate:1.15%
Dividend:0.28
Dividend Rate:0.70%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Faron reappoints key members to Nomination Board as cancer immunotherapy pipeline advances

TIPRANKS
·
Oct 06

Trump: Thanks Howard Kessler for senior healthcare innovation

Trump's Truth Social latest posts
·
Oct 06

From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run

Bellwether Stocks Movement
·
Oct 06

Moderna (MRNA) Names A New COO, Is The Rally Already Priced In?

Simply Wall St.
·
Oct 06

Moderna COO Juan Andres Files Initial Beneficial Ownership Statement

Reuters
·
Oct 06

Moderna Inc. Stock Rises 6.9%, Outperforms Peers

Dow Jones
·
Oct 06

Twist Bioscience CEO Emily Leproust Disposes of $8.77 Million in Common Shares

Reuters
·
Oct 06

IntegraGen Faces Judicial Liquidation as Court Weighs Takeover Bids

TIPRANKS
·
Oct 06

Moderna Inc Stock (MRNA) Moved Up by 5.71% on Oct 5: What Investors Need To Know

TradingKey
·
Oct 06

Vortex Energy Launches Study on Natural Hydrogen and Helium at Robinsons River Salt Project

TIPRANKS
·
Oct 06

Cboe data shows mixed options sentiment in Moderna with shares up 0.52%

TIPRANKS
·
Oct 05

Revolution Medicines Starts Phase 3 Trial of Rasonque-Zoldonrasib Combo in First-Line Metastatic RAS G12D Pancreatic Cancer

Reuters
·
Oct 05

Revolution Medicines Begins Treating Patients in Phase 3 Rasolute 309 Trial Evaluating Rasonque™ (Daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic Ras G12d Pancreatic Cancer

THOMSON REUTERS
·
Oct 05

Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease

GlobeNewswire
·
Oct 05

Celcuity Announces Multiple Presentations At The European Society For Medical Oncology (ESMO) Congress 2026

GlobeNewswire
·
Oct 05

Revolution Medicines, Inc. : Leerink Partners Resumes Coverage with Outperform Rating; Price Target $288

THOMSON REUTERS
·
Oct 05

Gene Editing, Protein Electron Transfer, Self-Assembled Monolayers 鈥?Which Will Win the Nobel Prize in Chemistry? Two Experts Share Their Predictions

Deep News
·
Oct 04

Twist Bioscience (TWST) Rallies As Growth Narrative Tests Whether The Stock Is Already Pricey

Simply Wall St.
·
Oct 04

ADPT, MRNA, CRWV, NBIS, JAZZ trending with analysts

TIPRANKS
·
Oct 03

Cboe data shows mixed options sentiment in Moderna with shares down 1.81%

TIPRANKS
·
Oct 02